HiActi® Recombinant Human VEGF121 Protein 重组人血管内皮生长因子121

Scan for product

HEK293细胞表达系统血管生成研究受体结合研究

Product no.91518ES Sizes3 options SourceYeasen · Official

Cat. No. 91518ES25

现货 $1,885.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

91518ES25 25 μg $1,885.00 现货 Enquire

91518ES60 100 μg $5,655.00 现货 Enquire

91518ES76 500 μg $16,965.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No91518ES

Specification高纯度、高活性、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293细胞表达系统

应用方法 血管生成研究研究血管生长和通透性 受体结合研究研究VEGF与受体的相互作用

适用物种种属人

检测方法 SDS-PAGE SEC-HPLC ELISA

生物特性参数 蛋白类型重组人血管内皮生长因子121 (rhVEGF121) 种属来源Human 生物活性描述ELISA Data: Immobilized Human VEGF121 No Tag at 0.5μg/ml (100μl/well) on the plate. Dose response curve for Human VEGF R1 His Tag with the EC50 of 19.1ng/ml determined by ELISA. 产品别称VEGF VEGFA MVCD1 VAS VEGFMGC70609 VPF RP1-261G23.1 MGC70609 Accession号P15692-9

技术参数纯度>95% as determined by Bis-Tris PAGE; >90% as determined by HPLC. 内毒素水平< 1.0 EU per μg by the LAL method. 分子量Predicted MW 14.07 kDa; due to glycosylation migrates to 15-25 kDa by Bis-Tris PAGE. 表达序列Ala27-Arg147 制剂形式Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. 复溶方法Centrifuge before opening. Reconstitute the lyophilized protein in distilled water to a concentration of more than 100 μg/mL. Aliquot to avoid repeated freeze-thaw. 表达系统HEK293 标签No Tag 外观Lyophilized Powder 储存条件-25 ~ -15℃保存，有效期1年；复溶后-85 ~ -65℃保存，3个月有效期。 pH7.4